Why is depression more prevalent in women?

作者: Paul Albert

DOI: 10.1503/JPN.150205

关键词:

摘要: Major depression is a chronic illness with high prevalence and major component of disease burden. Depressive disorders were the second leading cause years lived disability in 2010 Canada, United States globally.1,2 When depression-related deaths due to suicide stroke are considered, has third highest global burden disease.3 growing overall Canada around world; it predicted be by 2030, already women worldwide.4 Between 1990 depressive disorder showed 75% increase disability-adjusted life years,1 greatest after Alzheimer disease; comparison, was 43%.2 At same time, female:male ratio from remained unchanged at 1.7:1. Although differences socioeconomic factors, including abuse, education income, may impact higher rate women,5 this editorial focuses on biological contributors that experimentally tractable help understand how why more prevalent lead better treatments. The than men;6,7 its annual 5.5% 3.2%, respectively, representing 1.7-fold greater incidence women.1,8 In 5.0% 2.9% men 2002 (1.7-fold women) increased 5.8% 3.6%, 2012 (1.6-fold women).9,10 The finding similar ratios developed countries globally suggests differential risk primarily stem sex depend less race, culture, diet, numerous other potentially confounding social economic factors. There no clear evidence where have markedly lower status there equal footing.5 Depression twice as young (ages 14–25 yr), but decreases age.9,10 Indeed, starting puberty, for mental globally.1 Importantly, before girls boys rates depression; perhaps even boys.6 ages older 65 years, both show decline rates, becomes between them.9,11 A also reflected prescriptions antidepressant medications. 2007 2011, antidepressants prescribed often (9.3% v. 4.2% patients aged 25–44 yr, 2.2-fold; 17.2% 8.2% 45–64 2.1-fold).12 age discrepancy peaks (age yr)10 use (> 45 yr) adults not always receive treatment until many onset illness. This delay medication could contribute during adolescence adulthood would important study rigorously comparing treated nontreated cohorts. Delay might reflect stigma or underdiagnosis adolescence. New antistigma educational programs targeted youth reduce group.13 Why then among women? triggers appear differ, presenting internalizing symptoms externalizing symptoms.14 For example, dizygotic twins, displayed sensitivity interpersonal relationships, whereas external career goal-oriented factors.15 Women experience specific forms illness, premenstrual dysphoric disorder, postpartum postmenopausal anxiety, associated changes ovarian hormones women. However, underlying mechanisms remain unclear; thus, treatments been developed. The fact correlates hormonal women, particularly prior menstruation, following pregnancy perimenopause, female fluctuations trigger depression. most preclinical studies focus males avoid variability behaviour menstrual cycle. Nevertheless, primate rodent consistently implicate role hormones, such estrogen, Perhaps naturalistic date address involved small groups (n = 4–5) macaque primates formed lifelong hierarchies dominant subordinate females. latter depression-like phenotype16 brain-wide decrease serotonin 1A (5-HT1A) receptor levels decreased hippocampal volume.17,18 Interestingly, reduced volume extensive monkeys ovarian-intact monkeys, suggesting function protective. Consistent finding, appears perimenopausal transition.19 Emerging indicates hormone replacement therapy, period, can effective prevention women.20 Another involving macaques examined relocation stress–sensitive alterations their cycles behaviours reductions brain system.21 light, recent indicated who reported using an oral contraceptive (especially monophasic contraceptives) anxiety compared nonusers,22 moderating cycling estrogen Taken together these suggest protective effect pathology underlies depression. Why do men, lack systemic Accumulating research shown male testosterone converted into endogenous aromatase (CYP19). Estrogen mediate actions through receptors expressed throughout β).23 addition, presence androgen confer protection, example neurons.24 Since does cycle consistent protection men. sexually dimorphic nuclei, hypothalamus, so probably complex owing only differences, developmental circuitry.23 In fundamental terms, difference reflects different: 2 copies X chromosome, while 1 copy each Y chromosomes, being present Understanding genetic confers sexual predisposition complex, multilevel puzzle remains clarified. Society-driven factors likely origin, physical strength personality traits, what needs change attitudes promote equality; yet, occurring West yielded ratio.5 despite complexity, variation strategies mitigate Identifying ligands specifically target (e.g., receptor-β-selective ligands) protect adverse effects therapy.25

参考文章(26)
L. Trevor Young, What is the best treatment for bipolar depression Journal of Psychiatry & Neuroscience. ,vol. 33, pp. 487- 488 ,(2008)
Amanda J. Baxter, Kate M. Scott, Alize J. Ferrari, Rosana E. Norman, Theo Vos, Harvey A. Whiteford, Challenging the myth of an "epidemic" of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depression and Anxiety. ,vol. 31, pp. 506- 516 ,(2014) , 10.1002/DA.22230
Carol A. Shively, Thomas C. Register, David P. Friedman, Timothy M. Morgan, Jalonda Thompson, Tasha Lanier, Social stress-associated depression in adult female cynomolgus monkeys (Macaca fascicularis) Biological Psychology. ,vol. 69, pp. 67- 84 ,(2005) , 10.1016/J.BIOPSYCHO.2004.11.006
Daniel E. Ford, Thomas P. Erlinger, Depression and C-Reactive Protein in US Adults Archives of Internal Medicine. ,vol. 164, pp. 1010- 1014 ,(2004) , 10.1001/ARCHINTE.164.9.1010
Harvey A Whiteford, Louisa Degenhardt, Jürgen Rehm, Amanda J Baxter, Alize J Ferrari, Holly E Erskine, Fiona J Charlson, Rosana E Norman, Abraham D Flaxman, Nicole Johns, Roy Burstein, Christopher JL Murray, Theo Vos, None, Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The Lancet. ,vol. 382, pp. 1575- 1586 ,(2013) , 10.1016/S0140-6736(13)61611-6
Carol A. Shively, David P. Friedman, H. Donald Gage, Michael C. Bounds, Clive Brown-Proctor, Joseph B. Blair, Jessica A. Henderson, Michael A. Smith, Nancy Buchheimer, Behavioral Depression and Positron Emission Tomography–Determined Serotonin 1A Receptor Binding Potential in Cynomolgus Monkeys Archives of General Psychiatry. ,vol. 63, pp. 396- 403 ,(2006) , 10.1001/ARCHPSYC.63.4.396
Stan Kutcher, Alexa Bagnell, Yifeng Wei, Mental Health Literacy in Secondary Schools Child and Adolescent Psychiatric Clinics of North America. ,vol. 24, pp. 233- 244 ,(2015) , 10.1016/J.CHC.2014.11.007
Jennifer L. Gordon, Susan S. Girdler, Hormone Replacement Therapy in the Treatment of Perimenopausal Depression Current Psychiatry Reports. ,vol. 16, pp. 517- ,(2014) , 10.1007/S11920-014-0517-1
Jill M. Cyranowski, Ellen Frank, Elizabeth Young, M. Katherine Shear, Adolescent Onset of the Gender Difference in Lifetime Rates of Major Depression Archives of General Psychiatry. ,vol. 57, pp. 21- 27 ,(2000) , 10.1001/ARCHPSYC.57.1.21
Alize J Ferrari, Rosana E Norman, Greg Freedman, Amanda J Baxter, Jane E Pirkis, Meredith G Harris, Andrew Page, Emily Carnahan, Louisa Degenhardt, Theo Vos, Harvey A Whiteford, None, The burden attributable to mental and substance use disorders as risk factors for suicide: Findings from the Global Burden of Disease Study 2010 PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0091936